铭鸿体育资讯网

PharmTech Weekly Roundup—August 28, 2026 Author(s)Susan Haigney This week’s PharmTech.com content covered AI agent authority, hold-time and nitrosamine risk frameworks, biologics formulation, 3D bioprinting, and major oncology and dealmaking news.

2026-09-01 10:08:36 水华谈谈科技科技

PharmTech Weekly Roundup—August 28, 2026

Author(s)Susan Haigney

This week’s PharmTech.com content covered AI agent authority, hold-time and nitrosamine risk frameworks, biologics formulation, 3D bioprinting, and major oncology and dealmaking news.

阅读：0 点赞：0

PharmTech Weekly Roundup—August 28, 2026 Author(s)Susan Haigney This week’s PharmTech.com content covered AI agent authority, hold-time and nitrosamine risk frameworks, biologics formulation, 3D bioprinting, and major oncology and dealmaking news. ​

热门分类

PharmTech Weekly Roundup—August 28, 2026 Author(s)Susan Haigney This week’s PharmTech.com content covered AI agent authority, hold-time and nitrosamine risk frameworks, biologics formulation, 3D bioprinting, and major oncology and dealmaking news.